Fatima Rizvi

Fatima Rizvi is a Scientist in Metabolism and Aging with a Ph.D. in Biological Sciences and over eight years of research experience in both academia and industry. Presently, they work as a Senior Scientist at AstraZeneca, where they lead innovative research on preclinical epigenetic interventions for liver diseases at NewLimit. Previously, Fatima held roles as a Postdoctoral Fellow at Boston University, a Research Scientist, and a Senior Demonstrator at Sanjay Gandhi Postgraduate Institute of Medical Sciences. They have authored significant publications and are a Diplomate of the American Board of Toxicology, reflecting their dedication to advancing biotherapeutics and liver health.